Skip to main content
. 2015 Aug 24;10(5):2888–2894. doi: 10.3892/ol.2015.3628

Figure 1.

Figure 1.

Changes in plasma EBV-DNA prior and subsequent to treatment. (A) Rates of positive plasma EBV-DNA detection in healthy controls and NPC patients. (B) Levels of plasma EBV-DNA in healthy controls and NPC patients. (C) Rates of positive and negative plasma EBV-DNA detection in NPC patients prior and subsequent to treatment. (D) Levels of plasma EBV-DNA in NPC patients prior and subsequent to treatment. (E) Changes in plasma EBV-DNA levels in 277 NPC patients prior and subsequent to treatment. (F) Rates of positive plasma EBV-DNA detection in 208 NPC patients prior and subsequent to treatment. EBV, Epstein-Barr virus; NPC, nasopharyngeal carcinoma.